Pyogenic liver abscess associated with
Invasive liver abscess syndrome
Klebsiella oxytoca
Pyogenic liver abscess
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
17
04
2023
revised:
13
10
2023
accepted:
23
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
A pyogenic liver abscess (PLA) is a space-occupying lesion in the liver that is associated with significant morbidity and mortality. We herein present the case of a Japanese 76-year-old man who visited our hospital with fever and back pain lasting 3 weeks after endoscopic treatment for common bile duct stones. He was accompanied by poorly controlled diabetes mellitus (DM) with an HbA1c of 9.7 %. Laboratory tests disclosed elevated C-reactive protein level (22.1 mg/dL) and white cell count (11,910/μL). Abdominal computed tomography (CT) revealed hypodense lesions in the right liver lobe, with abdominal ultrasonography showing an echogenicity-mixed hypoechoic lesion. Percutaneous needle aspiration of a liver lesion was performed under suspicion of a PLA. Subsequent enhanced CT and magnetic resonance imaging confirmed the hepatic lesions in the right lobe as well as a septic pulmonary embolism, right hepatic vein thrombosis, spondylodiscitis, and a retroperitoneal abscess. Gram staining of the abscess drainage revealed gram-negative bacteria. The above findings indicated invasive liver abscess syndrome (ILAS) caused by
Identifiants
pubmed: 38027784
doi: 10.1016/j.heliyon.2023.e21537
pii: S2405-8440(23)08745-5
pmc: PMC10660025
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e21537Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
United European Gastroenterol J. 2021 Nov;9(9):1039-1047
pubmed: 34329537
Arch Intern Med. 2002 May 13;162(9):1021-7
pubmed: 11996612
Int J Surg Case Rep. 2017;41:180-183
pubmed: 29096338
Liver Int. 2021 Apr;41(4):810-818
pubmed: 33314531
Am J Gastroenterol. 2010 Jan;105(1):117-24
pubmed: 19888200
Lancet Infect Dis. 2012 Nov;12(11):881-7
pubmed: 23099082
Microbes Infect. 2004 Nov;6(13):1191-8
pubmed: 15488738
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0218321
pubmed: 35007133
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
IDCases. 2020 Feb 28;20:e00736
pubmed: 32211296
Clin Imaging. 2006 Jan-Feb;30(1):63-5
pubmed: 16377489
Am J Surg. 1973 Jan;125(1):70-9
pubmed: 4566907
Taehan Yongsang Uihakhoe Chi. 2020 Nov;81(6):1448-1452
pubmed: 36237704
Infect Immun. 2000 Feb;68(2):953-5
pubmed: 10639470
Arch Intern Med. 1986 Oct;146(10):1913-6
pubmed: 3532983
Intern Med. 2017 Nov 15;56(22):3121-3122
pubmed: 28943583
Eur J Clin Microbiol Infect Dis. 2002 Jun;21(6):419-26
pubmed: 12111596
Clin J Gastroenterol. 2020 Oct;13(5):927-934
pubmed: 32638229
Med J Armed Forces India. 2016 Dec;72(Suppl 1):S59-S61
pubmed: 28050072
Pathogens. 2023 Apr 29;12(5):
pubmed: 37242331
Clin Infect Dis. 2006 May 15;42(10):1351-8
pubmed: 16619144
J Microbiol Immunol Infect. 2016 Oct;49(5):646-653
pubmed: 25442876
Clin Infect Dis. 1997 Jun;24(6):1217-22
pubmed: 9195086
Cureus. 2023 Jan 30;15(1):e34365
pubmed: 36726765
CMAJ Open. 2018 Dec 3;6(4):E580-E586
pubmed: 30510041
Gastroenterol Res Pract. 2022 Apr 15;2022:3777122
pubmed: 35462985